Mast cells and complement system: Ancient interactions between components of innate immunity.
C3aR
C5aR
inflammation
innate immunity
urticaria
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
25
10
2019
revised:
09
04
2020
accepted:
26
04
2020
pubmed:
24
5
2020
medline:
15
5
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
The emergence and evolution of the complement system and mast cells (MCs) can be traced back to sea urchins and the ascidian Styela plicata, respectively. Acting as a cascade of enzymatic reactions, complement is activated through the classical (CP), the alternative (AP), and the lectin pathway (LP) based on the recognized molecules. The system's main biological functions include lysis, opsonization, and recruitment of phagocytes. MCs, beyond their classic role as master cells of allergic reactions, play a role in other settings, as well. Thus, MCs are considered as extrahepatic producers of complement proteins. They express various complement receptors, including those for C3a and C5a. C3a and C5a not only activate the C3aR and C5aR expressing MCs but also act as chemoattractants for MCs derived from different anatomic sites, such as from the bone marrow, human umbilical cord blood, or skin in vitro. Cross talk between MCs and complement is facilitated by the production of complement proteins by MCs and their activation by the MC tryptase. The coordinated activity between MCs and the complement system plays a key role, for example, in a number of allergic, cutaneous, and vascular diseases. At a molecular level, MCs and complement system interactions are based on the production of several complement zymogens by MCs and their activation by MC-released proteases. Additionally, at a cellular level, MCs act as potent effector cells of complement activation by expressing receptors for C3a and C5a through which their chemoattraction and activation are mediated by anaphylatoxins in a paracrine and autocrine fashion.
Substances chimiques
Receptors, Complement
0
Complement C5a
80295-54-1
Complement System Proteins
9007-36-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2818-2828Informations de copyright
© 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Liszewski MK, Kemper C. Complement in motion: the evolution of CD46 from a complement regulator to an orchestrator of normal cell physiology. J Immunol. 2019;203(1):3-5.
Smith LC, Clow LA, Terwilliger DP. The ancestral complement system in sea urchins. Immunol Rev. 2001;180:16-34.
Nonaka M. Evolution of the complement system. Subcell Biochem. 2014;80:31-43.
Levashina EA, Moita LF, Blandin S, Vriend G, Lagueux M, Kafatos FC. Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae. Cell. 2001;104(5):709-718.
Lubbers R, van Essen MF, van Kooten C, Trouw LA. Production of complement components by cells of the immune system. Clin Exp Immunol. 2017;188(2):183-194.
Arbore G, Kemper C, Kolev M. Intracellular complement - the complosome - in immune cell regulation. Mol Immunol. 2017;89:2-9.
Andrasfalvy M, Prechl J, Hardy T, Erdei A, Bajtay Z. Mucosal type mast cells express complement receptor type 2 (CD21). Immunol Lett. 2002;82(1-2):29-34.
Fukuoka Y, Hite MR, Dellinger AL, Schwartz LB. Human skin mast cells express complement factors C3 and C5. J Immunol. 2013;191(4):1827-1834.
Nilsson G, Johnell M, Hammer CH, et al. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol. 1996;157(4):1693-1698.
Lipitsa T, Naukkarinen A, Laitala J, Harvima IT. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase. Arch Dermatol Res. 2016;308(8):575-584.
Leung CT, Li A, Banerjee J, et al. The role of activated adenosine receptors in degranulation of human LAD2 mast cells. Purinergic Signal. 2014;10(3):465-475.
Skoglund C, Wettero J, Tengvall P, Bengtsson T. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets. Immunobiology 2010;215(12):987-995.
van Schaarenburg RA, Suurmond J, Habets KL, et al. The production and secretion of complement component C1q by human mast cells. Mol Immunol. 2016;78:164-170.
Geller A, Yan J. The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy. Front Immunol. 2019;10:1074.
Bohlson SS, Garred P, Kemper C, Tenner AJ. Complement nomenclature-deconvoluted. Front Immunol. 2019;10:1308.
Rahkola D, Laitala J, Siiskonen H, Pelkonen J, Harvima IT. Mast cells are a marked source for complement C3 products that associate with increased CD11b-positive cells in keratinocyte skin carcinomas. Cancer Invest. 2019;37(2):73-84.
Drouin SM, Kildsgaard J, Haviland J, et al. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol. 2001;166(3):2025-2032.
Brodsky RA. Complement in hemolytic anemia. Blood. 2015;126(22):2459-2465.
Hill A, DeZern AE, Kinoshita T, Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028.
Kinoshita T. Congenital defects in the expression of the glycosylphosphatidylinositol-anchored complement regulatory proteins CD59 and decay-accelerating factor. Semin Hematol. 2018;55(3):136-140.
Parente R, Clark SJ, Inforzato A, Day AJ. Complement factor H in host defense and immune evasion. Cell Mol Life Sci. 2017;74(9):1605-1624.
Zoshima T, Hara S, Yamagishi M, et al. Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits. Sci Rep. 2019;9(1):7857.
Simon TL, Kalina U, Laske R, Mycroft S, Widmer E, Roth NJ. Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema. Allergy Asthma Proc. 2019;41(2):99-107.
Kaplan AP, Pawaskar D, Chiao J. C1 inhibitor activity and angioedema attacks in patients with hereditary angioedema. J Allergy And Clin Immun Pract. 2019;8(3):892-900.
Bettoni S, Shaughnessy J, Maziarz K, et al. C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections. JCI insight. 2019;4(23):e131886. https://doi.org/10.1172/jci.insight.131886.
Ram S, Cullinane M, Blom AM, et al. C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae. Int Immunopharmacol. 2001;1(3):423-432.
Singh B, Su YC, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol. 2010;78(3):545-560.
Leung LLK, Morser J. Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity. J Thromb Haemost. 2018;16(8):1474-1486.
Johnson AR, Hugli TE, Muller-Eberhard HJ. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975;28(6):1067-1080.
Rochowiak A, Niemir ZI. The structure and role of CR1 complement receptor in physiology. Pol Merkur Lekarski. 2010;28(163):79-83.
Khera R, Das N. Complement Receptor 1: disease associations and therapeutic implications. Mol Immunol. 2009;46(5):761-772.
Wan H, Hu JP, Tian XH, Chang S. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d. Phys Chem Chem Phys. 2013;15(4):1241-1251.
Lukacsi S, Nagy-Balo Z, Erdei A, Sandor N, Bajtay Z. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes. Immunol Lett. 2017;189:64-72.
Zhang Y, Yan X, Zhao T, et al. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice. Clin Exp Immunol. 2017;189(1):60-70.
Li XX, Lee JD, Kemper C, Woodruff TM. The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity. J Immunol. 2019;202(12):3339-3348.
Wiesmann C, Katschke KJ, Yin J, et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature. 2006;444(7116):217-220.
Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol. 2005;42(5):581-587.
Rosenkranz AR, Coxon A, Maurer M, et al. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol. 1998;161(12):6463-6467.
Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol. 2013;13(5):362-375.
Elieh-Ali-Komi D, Cao Y. Role of mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Rev Allergy Immunol. 2017;52(3):436-445.
Komi DEA, Redegeld FA. Role of mast cells in shaping the tumor microenvironment. Clin Rev Allergy Immunol. 2019;58(3):313-325.
Leist M, Sunder CA, Drube S, et al. Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiation. Exp Dermatol. 2017;26(3):255-262.
Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990;63(1):213-224.
Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol. 1995;107(1-3):51-53.
Elieh Ali Komi D, Bjermer L. Mast cell-mediated orchestration of the immune responses in human allergic asthma Current Insights. Clin Rev Allergy Immunol. 2019;56(2):234-247.
Saluja R, Hawro T, Eberle J, Church MK, Maurer M. Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways. J Biol Regul Homeost Agents. 2014;28(4):575-585.
Westerberg CM, Ulleras E, Nilsson G. Differentiation of mast cell subpopulations from mouse embryonic stem cells. J Immunol Methods. 2012;382(1-2):160-166.
Wang M, Saxon A, Diaz-Sanchez D. Early IL-4 production driving Th2 differentiation in a human in vivo allergic model is mast cell derived. Clin Immunol. 1999;90(1):47-54.
Merz H, Kaehler C, Hoefig KP, et al. Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice. Oncotarget. 2010;1(2):104-119.
Komi DEA, Khomtchouk K, Santa Maria PL. A review of the contribution of mast cells in wound healing: involved molecular and cellular mechanisms. Clin Rev Allergy Immunol. 2019;58(3):298-312.
Elieh Ali Komi D, Grauwet K. Role of mast cells in regulation of T cell responses in experimental and clinical settings. Clin Rev Allergy Immunol. 2018;54(3):432-445.
Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol. 2014;14(7):478-494.
Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014;5:569.
Mukai K, Tsai M, Saito H, Galli SJ. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev. 2018;282(1):121-150.
Caughey GH. Mast cell proteases as pharmacological targets. Eur J Pharmacol. 2016;778:44-55.
Maaninka K, Nguyen SD, Mayranpaa MI, et al. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding. Atherosclerosis. 2018;275:390-399.
Fukuoka Y, Xia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz LB. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol. 2008;180(9):6307-6316.
Edelson BT, Li Z, Pappan LK, Zutter MM. Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin. Blood. 2004;103(6):2214-2220.
Edelson BT, Stricker TP, Li Z, et al. Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Blood. 2006;107(1):143-150.
Arizmendi N, Kulka M. Adenosine activates Galphas proteins and inhibits C3a-induced activation of human mast cells. Biochem Pharmacol. 2018;156:157-167.
Bekassy ZD, Kristoffersson AC, Rebetz J, Tati R, Olin AI, Karpman D. Aliskiren inhibits renin-mediated complement activation. Kidney Int. 2018;94(4):689-700.
Hartmann K, Henz BM, Kruger-Krasagakes S, et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997;89(8):2863-2870.
Schafer B, PiliponskyAM, Oka T, et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol. 2013;131(2):541-548.
Dalrymple NA, Mackow ER. Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol. 2012;86(12):6408-6415.
Purwar R, Wittmann M, Zwirner J, et al. Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J Immunol. 2006;177(7):4444-4450.
Subramanian H, Gupta K, Guo Q, Price R, Ali H. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization. J Biol Chem. 2011;286(52):44739-44749.
Subramanian H, Kashem SW, Collington SJ, Qu H, Lambris JD, Ali H. PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol Pharmacol. 2011;79(6):1005-1013.
Kordowski A, Reinicke AT, Wu D, et al. C5a receptor 1(-/-) mice are protected from the development of IgE-mediated experimental food allergy. Allergy. 2019;74(4):767-779.
Ali H. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol Lett. 2010;128(1):36-45.
Lohman RJ, Hamidon JK, Reid RC, et al. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nat Commun. 2017;8(1):351.
Maeno Y, Mori Y, Iwasa M, Inoue H, Takabe F. Complement component C3a or C3a desArg as a new marker for estimation of local vital reactions in incised skin wounds. Forensic Sci Int. 1992;55(1):37-44.
Kashem SW, Subramanian H, Collington SJ, Magotti P, Lambris JD, Ali H. G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. Eur J Pharmacol. 2011;668(1-2):299-304.
Passante E, Ehrhardt C, Sheridan H, Frankish N. RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflam Res. 2009;58(9):611-618.
Oskeritzian CA, Zhao W, Min HK, et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol. 2005;115(6):1162-1168.
Stone SF, Isbister GK, Shahmy S, et al. Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation. PLoS Negl Trop Dis. 2013;7(7):e2326.
Xie P, Nishiura H, Semba U, et al. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells. Int Immunopharmacol. 2012;12(1):158-168.
Dang L, He L, Wang Y, Xiong J, Bai B, Li Y. Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice. Mol Med Rep. 2015;11(6):4183-4189.
Oksjoki R, Kovanen PT, Meri S, Pentikainen MO. Function and regulation of the complement system in cardiovascular diseases. Front Biosci. 2007;12:4696-4708.
Mast KPT. Cells as potential accelerators of human atherosclerosis-from early to late lesions. Int J Mol Sci. 2019;20(18):4479.
Kovanen PT, Bot I. Mast cells in atherosclerotic cardiovascular disease - activators and actions. Eur J Pharmacol. 2017;816:37-46.
Oksjoki R, Laine P, Helske S, et al. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis. 2007;195(1):90-99.
Laine P, Pentikainen MO, Wurzner R, et al. Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J cardiol. 2002;90(4):404-408.
Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92(5):1084-1088.
de Vries MR, Wezel A, Schepers A, et al. Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovasc Res. 2013;97(2):311-320.
Wezel A, de Vries MR, Lagraauw HM, et al. Complement factor C5a induces atherosclerotic plaque disruptions. J Cell Mol Med. 2014;18(10):2020-2030.
Komi DEA, Rambasek T, Wohrl S. Mastocytosis: from a molecular point of view. Clin Rev Allergy Immunol. 2018;54(3):397-411.
Nunez-Lopez R, Escribano L, Schernthaner GH, et al. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol. 2003;120(2):257-265.
Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018;40(1):37-48.
Ogembo JG, Kannan L, Ghiran I, et al. Human complement receptor type 1/CD35 is an epstein-barr virus receptor. Cell Rep. 2013;3(2):371-385.
Langeggen H, Berge KE, Johnson E, Hetland G. Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro. Inflammation. 2002;26(3):103-110.
Fu H, Liu B, Frost JL, et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Abeta by microglia. Glia. 2012;60(6):993-1003.
Czirr E, Castello NA, Mosher KI, et al. Microglial complement receptor 3 regulates brain Abeta levels through secreted proteolytic activity. J Exp Med. 2017;214(4):1081-1092.
Graham IL, Anderson DC, Holers VM, Brown EJ. Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J Cell Biol. 1994;127(4):1139-1147.
Uotila LM, Aatonen M, Gahmberg CG. Integrin CD11c/CD18 alpha-chain phosphorylation is functionally important. J Biol Chem. 2013;288(46):33494-33499.